Major Challenges Limiting Liver Transplantation in the United States

Donor and Recipient IL28B Polymorphisms in HCV-Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation

(2011) M. Coto-Llerena et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Use of Tissue Plasminogen Activator in Liver Transplantation from Donation After Cardiac Death Donors

(2010) K. Hashimoto et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donation after Cardiac Death Liver Transplantation: Predictors of Outcome

(2010) A. K. Mathur et al.   AMERICAN JOURNAL OF TRANSPLANTATION

When Disaster Strikes: Death of a Living Organ Donor

(2010) L. E. Ratner et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Increased Costs of Donation After Cardiac Death Liver Transplantation

(2010) Colleen L. Jay et al.   ANNALS OF SURGERY

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials

(2010) Ahmed O. Kaseb et al.   CANCER

Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response

(2010) Céline Miroux et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C

(2010) Takasuke Fukuhara et al.   GASTROENTEROLOGY

The Epidemiology of Obesity

(2010) Dang M. Nguyen et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

(2010) Michael R. Charlton et al.   HEPATOLOGY

Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle

(2010) Sherrie Bhoori et al.   JOURNAL OF HEPATOLOGY

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

(2010) Paul Y Kwo et al.   LANCET

The biopsied donor liver: Incorporating macrosteatosis into high-risk donor assessment

(2010) Austin L. Spitzer et al.   LIVER TRANSPLANTATION

Effect of Calcineurin Inhibitors in the Outcome of Liver Transplantation in Hepatitis C Virus-Positive Recipients

(2010) Marina Berenguer et al.   TRANSPLANTATION

Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients

(2010) Susanne Beckebaum et al.   TRANSPLANTATION

Indications for and Survival After Liver Retransplantation

(2010) C.B. Bellido et al.   TRANSPLANTATION PROCEEDINGS

Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

(2010) Hui Liu   WORLD JOURNAL OF GASTROENTEROLOGY

Liver and Intestine Transplantation in the United States 1998-2007

(2009) C. L. Berg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Increased Expression of Regulatory Tr1 Cells in Recurrent Hepatitis C after Liver Transplantation

(2009) A. Carpentier et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up from a Single Center

(2009) M. E. de Vera et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series

(2009) J. V. Guarrera et al.   AMERICAN JOURNAL OF TRANSPLANTATION

One Hour Hypothermic Oxygenated Perfusion (HOPE) Protects Nonviable Liver Allografts Donated After Cardiac Death

(2009) Olivier de Rougemont et al.   ANNALS OF SURGERY

Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

(2009) H. Huynh et al.   CURRENT CANCER DRUG TARGETS

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

(2009) Andrew X. Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Complications of right lobe living donor liver transplantation

(2009) James W. Marsh et al.   JOURNAL OF HEPATOLOGY

Longterm Outcomes for Whole and Segmental Liver Grafts in Adult and Pediatric Liver Transplant Recipients: A 10-Year Comparative Analysis of 2,988 Cases

(2009) Johnny C. Hong et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

(2009) Sandrine Faivre et al.   LANCET ONCOLOGY

Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation

(2009) Jan Peveling-Oberhag et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolving Surgical Approaches in Liver Transplantation

(2009) Henrik Petrowsky et al.   SEMINARS IN LIVER DISEASE

The Dilemma of Living Liver Donor Death: to Report or not to Report?

(2009) Burckhardt Ringe et al.   TRANSPLANTATION

Inhibitory Effects of Cyclosporine on Human Regulatory T Cells In Vitro

(2009) C. Miroux et al.   TRANSPLANTATION PROCEEDINGS

Elevated CD4+/CD25+ T-cell Frequency and Function During Hepatitis C Virus Recurrence After Liver Transplantation

(2009) A. Perrella et al.   TRANSPLANTATION PROCEEDINGS

Indications and Management of Everolimus After Liver Transplantation

(2009) I. Bilbao et al.   TRANSPLANTATION PROCEEDINGS

Survival Outcomes Following Liver Transplantation (SOFT) Score: A Novel Method to Predict Patient Survival Following Liver Transplantation

(2008) A. Rana et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation

(2008) M. Berenguer et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection

(2008) B. J. Veldt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study†

(2008) C. E. Freise et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted

(2008) Elizabeth C. Verna et al.   Clinics in Liver Disease

Donor Morbidity After Living Donation for Liver Transplantation

(2008) Rafik M. Ghobrial et al.   GASTROENTEROLOGY

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

(2008) Marina Berenguer   JOURNAL OF HEPATOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2008) Michael A. Zimmerman et al.   LIVER TRANSPLANTATION

Report of the Paris consensus meeting on expanded criteria donors in liver transplantation

(2008) François Durand et al.   LIVER TRANSPLANTATION

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Whole Liver Versus Split Liver Versus Living Donor in the Adult Recipient???An Analysis of Outcomes by Graft Type

(2008) Abhinav Humar et al.   TRANSPLANTATION